ZYNE

Zynerba Pharmaceuticals, Inc

Delisted

ZYNE was delisted on the 10th of October, 2023.

61 hedge funds and large institutions have $12.5M invested in Zynerba Pharmaceuticals, Inc in 2019 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
61
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.16M
Puts
$2.09M
Net Calls
Net Calls Change

Top Buyers

1 +$1.49M
2 +$504K
3 +$486K
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$382K
5
PP
PDT Partners
New York
+$186K

Top Sellers

1 -$830K
2 -$607K
3 -$547K
4
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
-$427K
5
SIM
Spark Investment Management
New York
-$409K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$2.93M
2
$1.61M
3
$980K
4
$605K
5
$560K
6
$555K
7
$535K
8
$518K
9
$486K
10
$476K
11
$436K
12
$395K
13
$303K
14
$294K
15
$219K
16
$207K
17
$138K
18
$133K
19
$130K
20
$128K
21
$121K
22
$112K
23
$100K
24
$88K
25
$65K